BXC vs CLOV
BlueLinx Holdings Inc (BXC) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
BlueLinx Holdings Inc (BXC) is a industrial distribution company listed on NYSE.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BXC revenue for 2024-12-28 was $2.95B. Net income was $53.1M. Revenue was down 5.9% from 2023-12-30 to 2024-12-28. BXC currently screens at market cap $423.4M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BXC currently screens at market cap $423.4M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BXC and CLOV stock pages for the full models.
Not investment advice.